C18orf32 encodes a 76-residue protein of the UPF0729 family (DUF4512) with an N-terminal hydrophobic segment and a disordered C-terminal tail. The N-terminal region anchors the protein in the endoplasmic reticulum, and when cells are loaded with fatty acids a fraction moves onto nascent and mature lipid droplets. The protein turns over constitutively by ER-associated degradation through the E3 ligase gp78 (AMFR), derlin-1, VCP and the proteasome. In a genetic screen, C18orf32 was one of a small set of ER factors required for efficient removal of the inositol acyl chain from newly made GPI-anchored proteins by the deacylase PGAP1, and a homozygous frameshift variant causes an autosomal recessive GPI-biosynthesis-defect neurodevelopmental disorder (GPIBD25) with loss of this activity. How C18orf32 supports GPI-inositol deacylation is unknown, and it has no known enzymatic activity. A single recent study also places it on SEC22B-positive secretory autophagosomes with a role in lipid droplet secretion. An early overexpression screen reported that it can activate an NF-kappaB reporter, but this has not been followed up.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005515 protein binding | IPI PMID:23864651 The identification of novel proteins that interact with the ... | REMOVE | Summary: Interaction with GLP1R (P43220) from a membrane yeast two-hybrid (MYTH) screen using unliganded GLP-1 receptor as bait; bare protein binding carries no functional information. Reason: Generic protein binding is uninformative and no more specific molecular function can be derived. C18orf32 is not among the interactors the study followed up functionally, and it is not named in the cached main text, so the hit is a screen-level observation. A hydrophobic membrane-anchored microprotein is a typical MYTH prey. There is no other evidence linking C18orf32 to GLP-1 receptor signalling. Removal does not imply that the interaction is false. Supporting Evidence: PMID:23864651 A screen of a human fetal brain cDNA prey library with an unliganded human GLP-1R as bait in yeast revealed 38 novel interactor protein candidates. |
| GO:0005515 protein binding | IPI PMID:29275994 A Proximity Labeling Strategy Provides Insights into the Com... | REMOVE | Summary: Co-purification of S-tagged C18orf32 with derlin-1 (DERL1, Q9BUN8) in the context of its own ER-associated degradation. Reason: The interaction is real but reflects C18orf32 being an ERAD client that derlin-1 handles; it does not describe an activity that C18orf32 performs. Bare protein binding is uninformative, and no more specific MF (for example an adaptor activity) is supported, so the row is removed rather than rewritten. Supporting Evidence: PMID:29275994 Affinity purification revealed that c18orf32-S interacts with both derlin-1 and gp78 PMID:29275994 Thus, c18orf32 is constitutively degraded through a pathway that requires ubiquitin conjugation, VCP, and the proteasome. |
| GO:0005515 protein binding | IPI PMID:29275994 A Proximity Labeling Strategy Provides Insights into the Com... | REMOVE | Summary: Co-purification of S-tagged C18orf32 with the ERAD E3 ubiquitin ligase gp78 (AMFR, Q9UKV5), which is required for its degradation. Reason: C18orf32 is a substrate of gp78; binding to the ligase that degrades it is a property of the ligase's substrate recognition, not a molecular function of C18orf32. Bare protein binding is uninformative and no more specific MF is supported. Supporting Evidence: PMID:29275994 Affinity purification revealed that c18orf32-S interacts with both derlin-1 and gp78 |
| GO:0005783 endoplasmic reticulum | EXP PMID:35107634 C18orf32 loss-of-function is associated with a neurodevelopm... | ACCEPT | Summary: Immunofluorescence localisation of C18orf32 to the ER in the study describing the GPIBD25 frameshift variant. Reason: The ER localisation agrees with two independent studies (PMID:29275994, PMID:29255114) and with the ER-anchoring N-terminal hydrophobic region. The cached record is abstract-only; it reports the mutant protein in the ER, and the curator, who read the full text, presumably also saw the wild-type protein there. The ER is where GPI-inositol deacylation takes place, so this is the functionally relevant location. ORGANELLES check (2026-11-05, ER batch 2): ER residence is constitutive, not biosynthetic transit; the protein has no signal peptide, is held by its own N-terminal hydrophobic region, and is degraded in the ER by gp78/derlin-1 ERAD. Root row kept; the membrane sub-compartment is added as a separate NEW GO:0005789 row. Supporting Evidence: PMID:35107634 Immunofluorescence revealed that the mutant C18orf32 was localized to the endoplasmic reticulum and was also found as aggregates in the nucleus. |
| GO:0005783 endoplasmic reticulum | IDA PMID:29275994 A Proximity Labeling Strategy Provides Insights into the Com... | ACCEPT | Summary: GFP-tagged and endogenous C18orf32 are in the ER under basal conditions; the N-terminal hydrophobic domain is necessary and sufficient for ER targeting. Reason: Direct imaging plus fractionation and a domain-deletion analysis, in a full-text paper; consistent with constitutive ERAD of the protein. ORGANELLES check (2026-11-05, ER batch 2): the assay (GFP-fusion imaging, endogenous staining, calnexin co-staining, pellet versus buoyant fractions) shows the organelle; the membrane sub-compartment is recorded in a separate NEW GO:0005789 row rather than on this row. Supporting Evidence: PMID:29275994 In the absence of oleate, GFP-tagged c18orf32 was present in the ER (Figure S7A). PMID:29275994 These data indicate that the N-terminal hydrophobic domain is necessary and sufficient for recruitment of c18orf32 to ER and LDs. |
| GO:0005783 endoplasmic reticulum | IEA GO_REF:0000044 | ACCEPT | Summary: UniProt subcellular-location mapping to ER, derived from the experimental localisations in PMID:29275994 and PMID:35107634. Reason: Redundant with the experimental rows but correct. ORGANELLES check (2026-11-05, ER batch 2): the SL-0095 keyword rests on curated UniProt text tagged ECO:0000269 to PMID:29275994 and PMID:35107634, both read here, so the organelle claim holds. UniProt gives no ER sub-location, which is why the mapping stops at the root; the membrane is added as a NEW GO:0005789 row. Supporting Evidence: PMID:29275994 Together, these findings indicate that c18orf32 is an ER protein that traffics to emerging LDs. file:human/C18orf32/C18orf32-uniprot.txt SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:29275994, ECO:0000269|PubMed:35107634}. |
| GO:0005789 endoplasmic reticulum membrane | IC PMID:29275994 A Proximity Labeling Strategy Provides Insights into the Com... | NEW | Summary: Proposed sub-compartment. C18orf32 is held in the ER by its N-terminal hydrophobic region, a membrane anchor on the cytosolic face; the existing annotations stop at the organelle. Reason: ORGANELLES rule 4 (2026-11-05, ER batch 2). Lines that agree on the membrane rather than the lumen. (1) Sequence and targeting - the 76-residue chain has no signal peptide, so it cannot enter the lumen, and its N-terminal hydrophobic region (1-37) is necessary and sufficient for ER and lipid-droplet targeting; without it the protein is diffuse (PMID:29275994). The same region moves the protein onto the lipid-droplet monolayer, which only a protein embedded in the cytosolic leaflet of the ER bilayer can do, and PMID:41351175 models it as a helix whose residues 7-15 insert into the hydrophobic phase. (2) Fractionation - the endogenous, knockout-validated band is only in the pellet (ER membrane) and buoyant fractions, not the cytosol (PMID:29275994). (3) Turnover, supportive - degradation needs the membrane ERAD machinery gp78 and derlin-1, which dislocate membrane-embedded substrates. This is a constitutive membrane-anchored pool, not a cytosolic protein recruited to the ER surface, so the root-only rule for recruited pools does not apply. IC because UniProt annotates no TM segment and no carbonate extraction or protease-protection assay was done; the anchor may be monotopic (hairpin or amphipathic) rather than spanning; PMID:41351175 describes it as an "N-terminal amphiphilic helix", which favours a monotopic, membrane-embedded anchor. The membrane row still holds for a monotopic anchor, but not a bilayer-spanning topology. core_functions are unchanged. Supporting Evidence: PMID:29275994 In contrast, the c18orf32(Ξ1-37)-GFP mutant was diffusely distributed throughout the cell and was absent from LDs (Figure 6I). These data indicate that the N-terminal hydrophobic domain is necessary and sufficient for recruitment of c18orf32 to ER and LDs. PMID:29275994 Levels of c18orf32 in ER-enriched pellet fractions from gp78 KO cells were modestly increased PMID:29275994 Affinity purification revealed that c18orf32-S interacts with both derlin-1 and gp78 PMID:41351175 The hydrophobic segment (residues 7β15) likely inserted into the lipid dropletβs core PMID:41351175 interacting with LDs through its N-terminal amphiphilic helix |
| GO:0005811 lipid droplet | IDA PMID:29275994 A Proximity Labeling Strategy Provides Insights into the Com... | ACCEPT | Summary: Identified as a high-confidence lipid droplet protein by APEX2 proximity labelling; endogenous protein visualised on LDs with a knockout-validated antibody, found in buoyant fractions, and recruited to nascent LDs. Reason: Strong, multi-method evidence with controls for overexpression and for ER-wrapping artefacts. Independently supported by PMID:41351175. Supporting Evidence: PMID:29275994 Endogenous c18orf32 was distributed in puncta most apparent at the periphery of LD clusters, confirming that the localization of c18orf32 at LDs is not an artifact of overexpression (Figure 6C). PMID:41351175 We find that C18ORF32 localizes to the lipid droplets and autophagosomes, interacting with LDs through its N-terminal amphiphilic helix and with SEC22B via its C-terminal region. |
| GO:0005811 lipid droplet | IEA GO_REF:0000044 | ACCEPT | Summary: UniProt subcellular-location mapping to lipid droplet, derived from PMID:29275994. Reason: Redundant with the IDA row but correct. Supporting Evidence: PMID:29275994 Together, these findings indicate that c18orf32 is an ER protein that traffics to emerging LDs. |
| GO:0043123 positive regulation of canonical NF-kappaB signal transduction | HMP PMID:12761501 Large-scale identification and characterization of human gen... | MARK AS OVER ANNOTATED | Summary: C18orf32 was one of ~300 cDNAs that activated an NF-kappaB luciferase reporter when overexpressed in HEK293 cells in a genome-scale screen of 150,000 cDNAs. Reason: The only evidence is a hit in an overexpression reporter screen, which shows that excess protein can activate a reporter, not that the endogenous protein acts in NF-kappaB signalling. The cached record is abstract-only, so gene-level data could not be inspected, and the result is not contradicted. However, no study in the 23 years since has linked C18orf32 to NF-kappaB signalling. Every later functional study places it in the ER and on lipid droplets, in GPI-anchor processing, ERAD and lipid handling. Overexpression of an ER membrane protein that is normally degraded by ERAD could plausibly activate NF-kappaB indirectly through ER stress. The term is kept but flagged as not representing the gene's function. Supporting Evidence: PMID:12761501 For analysis of the NF-kappaB signaling pathway, we introduced each of the cDNAs into human embryonic kidney 293 cells and examined whether it activated the transcription of a luciferase reporter gene driven by a promoter containing the consensus NF-kappaB binding sites. |
Loading supporting contentβ¦
Download this section (compressed HTML)Q: How does C18orf32 support GPI-inositol deacylation by PGAP1? PMID:29255114 found PGAP1 expression, stability and localisation unchanged in knockout cells. Does C18orf32 bind PGAP1 or GPI-anchored protein precursors, or act indirectly, for example through ER lipid or calnexin-cycle homeostasis? The answer decides whether a GPI-anchor processing process term would describe participation or only necessity.
Suggested experts: Morihisa Fujita, Taroh Kinoshita
Q: Is the lipid droplet pool of C18orf32 functional, or is it a by-product of ER partitioning of a hairpin-like protein that is normally removed by ERAD? Can the secretory autophagy and lipid droplet secretion role proposed in PMID:41351175 be reproduced independently?
Suggested experts: James A Olzmann
Experiment: In C18orf32 knockout cells, test proximity labelling or co-immunoprecipitation of tagged C18orf32 with PGAP1 and with inositol-acylated GPI-AP precursors. Measure PGAP1 activity in vitro on microsomes from wild-type and knockout cells, with and without recombinant C18orf32. Ask whether the N-terminal ER-anchoring region or the disordered C-terminal tail is needed to rescue PIPLC sensitivity.
Hypothesis: C18orf32 acts directly on the PGAP1 deacylation step rather than indirectly through ER homeostasis.
Type: biochemical reconstitution and genetic rescue
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)